Search
for
Sort by
Research 721–750 of 1000+
- Immune privilege and alopecia areata
- 516 Possible role of ILC1 in the pathogenesis of alopecia areata (AA)
- LB1029 The common fragrance, linalool, promotes core hair follicle pathology events associated with frontal fibrosing alopecia through activating a cognate olfactory receptor in the bulge
- 1419 Pre-clinical in-vitro assays for high throughput screening of drug candidates for protection and restoration of immune privilege in alopecia areata
- 1432 IL-9/IL-9R signaling as a novel regulator of human hair follicle growth and immune privilege
- 584 Dandruff is associated with perturbations of hair follicle immune privilege, and the infundibular and epidermal immune microenvironment
- ESDR382 - Environmental pathobiology of frontal fibrosing alopecia (FFA): Does linalool promote FFA development and progression by inducing epithelial hair follicle stem cell damage and MICA expression in the bulge?
- 865 Single-cell protein activity inference analysis of full-thickness skin uncovers novel pathways and a rare Arg1+ macrophage population in AA
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- 1372 Biological effects of electrical epilation on human hair follicles and perifollicular skin ex vivo
- Cutaneous neuroimmunology – lessons from the hair follicle
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- 014 Tyrosine Kinase 2 Inhibition Ameliorates the Phenotype of Lesional Alopecia Areata Scalp Skin Ex Vivo, and Reverses the Induction of Human Alopecia Areata in a Humanized Mouse Model
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- The Clinical Presentation of Systemic Lupus Erythematosus
- Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review
- A Severe Case of Folliculitis Decalvans
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Tofacitinib for the treatment of lichen planopilaris: A case series
- JAK inhibitors and alopecia areata
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse
- Plasma Rich in Growth Factors as an Adjuvant Treatment for the Management of Frontal Fibrosing Alopecia: A Retrospective Observational Clinical Study
- Recurring Chemotherapy-Associated Alopecia Areata: Case Report and Literature Review
- Cyclosporine-Induced Alopecia in Childhood Nephrotic Syndrome – A Case Report
- Study of vitamin D deficiency in patients with alopecia areata attending a dermatology center in Iran
- The Specific Dermatoses of Pregnancy
- Navigating Rhupus Complexity
- Navigating Rhupus Complexity
- Retrospektive Analyse von Wirksamkeit, Sicherheit, prognostischen Parametern und Faktoren der Lebensqualität bei der topischen Immuntherapie der Alopecia areata mit Diphenylcyclopropenon